GSRCX
Price
$12.26
Change
+$0.03 (+0.25%)
Updated
Jul 10 closing price
Net Assets
408.34M
VFIAX
Price
$693.68
Change
-$5.54 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

GSRCX vs VFIAX

GSRCX vs VFIAX Comparison Chart in %
View a ticker or compare two or three
VS
GSRCX vs. VFIAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSRCX is a Buy and VFIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.67T vs. GSRCX (408M). VFIAX pays higher dividends than GSRCX: VFIAX (1.06) vs GSRCX (0.60). GSRCX was incepted earlier than VFIAX: GSRCX (21 years) vs VFIAX (26 years). GSRCX (2.04) is less costly to investors than VFIAX (0.04). GSRCX is a more actively managed with annual turnover of: 35.00 vs. VFIAX (2.00). GSRCX has a lower initial minimum investment than VFIAX: GSRCX (1000) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 21.06 vs. GSRCX (2.96). VFIAX return over 5 years is better than : 73.37 vs. GSRCX (-4.46).
GSRCXVFIAXGSRCX / VFIAX
Total Expense Ratio1.760.044,400%
Annual Report Gross Expense Ratio2.040.045,100%
Fund Existence21 years26 years-
Gain YTD11.79210.683110%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets408M1.67T0%
Annual Yield % from dividends0.601.0656%
Returns for 1 year2.9621.0614%
Returns for 3 years7.7568.3811%
Returns for 5 years-4.4673.37-6%
Returns for 10 years-35.27250.96-14%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPIX6.540.61
+10.29%
Cumberland Pharmaceuticals
BKV25.790.49
+1.94%
BKV Corp
XRTX2.03-0.02
-0.98%
XORTX Therapeutics Inc.
ORN13.35-0.38
-2.77%
Orion Group Holdings
JAZZ236.97-6.85
-2.81%
Jazz Pharmaceuticals plc